Skip to main content

Table 1 Demographic and disease-related characteristics of Korean adults with and without hypertension

From: Factors associated with dietary adherence to the guidelines for prevention and treatment of hypertension among Korean adults with and without hypertension

 

Total (n = 497)

Normotensives (n = 359)

Hypertensives (n = 138)

P-value

Sex (women)

346 (69.6)

254 (70.8)

92 (66.7)

0.44

Age (y)

56.9 ± 8.5

55.5 ± 8.8

60.7 ± 6.2

< 0.01

Education (college or higher)

195 (39.3)

155 (43.3)

40 (29.0)

< 0.01

Subjective economic status (low)

81 (16.3)

52 (14.5)

29 (21.0)

0.10

Cardiometabolic disease status

 Obesitya

155 (31.2)

88 (24.5)

67 (48.6)

< 0.01

 Diabetes mellitusb

46 (9.3)

23 (6.4)

23 (16.7)

< 0.01

 Dyslipidemiac

237 (47.7)

143 (39.8)

94 (68.1)

< 0.01

Family history of hypertension

229 (46.1)

150 (41.8)

79 (57.3)

< 0.01

Hypertension duration (years)

8.4 ± 6.6

Antihypertensive drug treatment (yes)

105 (93.8)

Frequency of BP measurement during the previous 1 year

  ≤ 4 times

267 (53.7)

236 (65.7)

31 (22.5)

< 0.01

 5–12 times

161 (32.4)

87 (24.2)

74 (53.6)

 

  > 12 times

69 (13.9)

36 (10.0)

33 (23.9)

 

Awareness of their own BP value (yes)

359 (72.2)

243 (67.7)

116 (84.1)

< 0.01

Lifestyle behaviors

113 (22.7)

86 (24.0)

27 (19.6)

0.35

Current non-smoking

454 (91.4)

328 (91.4)

126 (91.3)

1.00

Current non-drinking

191 (38.4)

142 (39.6)

49 (35.5)

0.47

Regular walking (≥60 min/day)

328 (66.0)

241 (67.1)

87 (63.0)

0.45

Dietary education over the past 1 year (yes)

72 (14.5)

58 (16.4)

13 (9.4)

0.07

  1. Abbreviations: BP blood pressure
  2. Values are presented as N (%) or mean ± SD
  3. aObesity was defined as a body mass index ≥25.0 kg/m2
  4. bDiabetes was defined as either a fasting glucose level ≥ 126 mg/dL or when participants self-reported anti-diabetic treatment, such as taking a hypoglycemic agent or insulin
  5. cDyslipidemia was defined if any one of hypercholesterolemia (serum cholesterol level ≥ 240 mg/dL or self-reported lipid-lowering drug use), hypertriglyceridemia (serum triacylglycerol level ≥ 200 mg/dL or self-reported lipid-lowering drug use), or low HDL-cholesterol (HDL cholesterol level < 40 mg/dL in men and < 50 mg/dL in women, respectively) is present